Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease

被引：11
|
作者：
Brickman, Adam M. [1 ,2 ,3 ]
Manly, Jennifer J. [1 ,2 ,3 ]
Honig, Lawrence S. [1 ,2 ,3 ]
Sanchez, Danurys [1 ,2 ,3 ]
Reyes-Dumeyer, Dolly [1 ,2 ,3 ]
Lantigua, Rafael A. [1 ,4 ]
Vonsattel, Jean Paul [1 ,4 ,5 ]
Teich, Andrew F. [1 ,5 ]
Kang, Min Suk [1 ]
Dage, Jeffrey L. [6 ,7 ]
Mayeux, Richard [1 ,2 ,3 ]
机构：
[1] Columbia Univ, Vagelos Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA
[2] Columbia Univ, Vagelos Coll Phys & Surg, GH Sergievsky Ctr, New York, NY 10027 USA
[3] Columbia Univ, Vagelos Coll Phys & Surg, Dept Neurol, New York, NY USA
[4] New York Presbyterian Hosp, New York, NY USA
[5] Columbia Univ, Vagelos Coll Phys & Surg, Dept Med, New York, NY USA
[6] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY USA
[7] Indiana Univ, Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA
来源：
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY | 2022年 / 9卷 / 05期
基金：
美国国家卫生研究院;
关键词：
DEMENTIA; TAU;
D O I：
10.1002/acn3.51529
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Blood-based phosphorylated tau (Ptau) 181 and 217 biomarkers are sensitive and specific for Alzheimer's disease. In this racial/ethnically diverse cohort study, participants were classified as biomarker positive (Ptau+) or negative (Ptau-) based on Ptau 181 and 217 concentrations and as cognitively impaired (Sym) or unimpaired (Asym). The four groups, Ptau-/Asym, Ptau+/Asym, Ptau-/Sym, and Ptau+/Sym, differed by age, APOE-4 allele frequency, total tau, neurofilament light chain, and cortical thickness measured by MRI. Our results add to increasing evidence that plasma Ptau 181 and 217 concentrations are valid Alzheimer's disease biomarkers in diverse populations.
引用
收藏
页码：756 / 761
页数：6
相关论文
共 50 条
  • [41] Plasma Alzheimer's disease biomarkers and cognitive progression in Parkinson's disease
    Pilotto, A.
    Ashton, N. J.
    Lupini, A.
    Battaglio, B.
    Gipponi, S.
    Cottini, E.
    Grossi, I.
    Salvi, A.
    de Petro, G.
    Pizzi, M.
    Blennov, K.
    Gonzalez, M.
    Aarsland, D.
    Zetterberg, H.
    Padovani, A.
    MOVEMENT DISORDERS, 2022, 37 : S546 - S547
  • [42] Plasma biomarkers for Alzheimer's
    Arnaud, Celia
    CHEMICAL & ENGINEERING NEWS, 2018, 96 (06) : 6 - 6
  • [43] Longitudinal Stability Evaluation of Biomarkers and Their Correlation in Cerebrospinal Fluid and Plasma from Patients with Alzheimer's Disease
    Hoglund, Kina
    Bogstedt, Anna
    Fabre, Susanne
    Aziz, Ali
    Annas, Peter
    Basun, Hans
    Minthon, Lennart
    Lannfelt, Lars
    Blennow, Kaj
    Andreasen, Niels
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 32 (04) : 939 - 947
  • [44] CORRELATION BETWEEN QUANTITATIVE STRUCTURAL NEUROIMAGING AND COGNITIVE STATUS IN ALZHEIMER'S DISEASE
    Bomboi, G.
    Vadala, R.
    Picconi, O.
    Pierallini, A.
    Guidoni, S. V.
    Caselli, G.
    Orzi, F.
    Giubilei, F.
    Bagnato, F.
    Giugni, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 351 - 351
  • [45] NEUROIMAGING BIOMARKERS IN HUNTINGTON'S DISEASE
    De Zande, Nadine A. Van
    Ghariq, Eidrees
    De Bresser, Jeroen Hjm
    Roos, Raymund Ac
    De Bot, Susanne T.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A36 - A36
  • [46] Clinical significance of plasma candidate biomarkers of Alzheimer's Disease
    Lewczuk, Piotr
    Lukaszewicz-Zajac, Marta
    Kornhuber, Johannes
    Mroczko, Barbara
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2024, 58 (04) : 363 - 379
  • [47] Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change
    Bermudez, Camilo
    Graff-Radford, Jonathan
    Syrjanen, Jeremy A.
    Stricker, Nikki H.
    Algeciras-Schimnich, Alicia
    Kouri, Naomi
    Kremers, Walter K.
    Petersen, Ronald C.
    Jack, Clifford R.
    Knopman, David S.
    Dickson, Dennis W.
    Nguyen, Aivi T.
    Reichard, R. Ross
    Murray, Melissa E.
    Mielke, Michelle M.
    Vemuri, Prashanthi
    ACTA NEUROPATHOLOGICA, 2023, 146 (01) : 13 - 29
  • [48] Preanalytical stability of plasma biomarkers for Alzheimer's disease pathology
    Sunde, Anita L.
    Alsnes, Ingvild V.
    Aarsland, Dag
    Ashton, Nicholas J.
    Tovar-Rios, Diego A.
    De Santis, Giovanni
    Blennow, Kaj
    Zetterberg, Henrik
    Kjosavik, Svein R.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2023, 15 (02)
  • [49] Associations of liver function with plasma biomarkers for Alzheimer’s Disease
    Bin Zhang
    Cheng Zhang
    YuYe Wang
    LeiAn Cheng
    Yu Wang
    YaNan Qiao
    Dantao Peng
    Neurological Sciences, 2024, 45 : 2625 - 2631
  • [50] The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
    Simren, Joel
    Leuzy, Antoine
    Karikari, Thomas K.
    Hye, Abdul
    Benedet, Andrea Lessa
    Lantero-Rodriguez, Juan
    Mattsson-Carlgren, Niklas
    Scholl, Michael
    Mecocci, Patrizia
    Vellas, Bruno
    Tsolaki, Magda
    Kloszewska, Iwona
    Soininen, Hilkka
    Lovestone, Simon
    Aarsland, Dag
    Hansson, Oskar
    Rosa-Neto, Pedro
    Westman, Eric
    Blennow, Kaj
    Zetterberg, Henrik
    Ashton, Nicholas J.
    ALZHEIMERS & DEMENTIA, 2021, 17 (07) : 1145 - 1156
12345